Drug Management of Prostate Cancer

Nonfiction, Health & Well Being, Medical, Specialties, Urology, Oncology
Cover of the book Drug Management of Prostate Cancer by , Springer New York
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9781603278294
Publisher: Springer New York Publication: September 14, 2010
Imprint: Springer Language: English
Author:
ISBN: 9781603278294
Publisher: Springer New York
Publication: September 14, 2010
Imprint: Springer
Language: English

Prostate cancer is the most common noncutaneous prostate cancer. Research has revealed several distinct malignancy and the second leading cause of cancer mechanisms of castration-resistant disease that may deaths among men in the United States. It is a critical converge in patients with disease progression on public health problem and remains incurable in the ADT. Many approaches are currently being evaluated metastatic setting with mortality that usually occurs as to improve the treatment of this condition and these a result of castration-resistant disease. fndings have identifed several potential targets for Since Huggins and Hodges’ report of the dra- therapeutic intervention. These include drugs that are matic clinical effects of suppressing serum testos- more active or less toxic chemotherapy agents; drugs terone levels in men with advanced prostate cancer that induce androgen deprivation; drugs that target in 1941, hormone therapy (also called androgen the androgen receptor and/or androgen synthesis; deprivation therapy [ADT]) has become widely drugs that target specifc pathways, including ang- accepted as the mainstay of therapy for the treat- genesis and tyrosine kinase inhibitors, endothelin ment of advanced prostate cancer. ADT combined antagonists and matrix metalloproteinase inhibitors; with radiation therapy is a standard of care in the and immunologic approaches. Many of these agents treatment of men with locally advanced prostate seem promising and the rationale and effcacy of cancer on the basis of evidence that shows improved these emerging therapies remain to be validated in survival. The role of ADT in the management of future clinical trials.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

Prostate cancer is the most common noncutaneous prostate cancer. Research has revealed several distinct malignancy and the second leading cause of cancer mechanisms of castration-resistant disease that may deaths among men in the United States. It is a critical converge in patients with disease progression on public health problem and remains incurable in the ADT. Many approaches are currently being evaluated metastatic setting with mortality that usually occurs as to improve the treatment of this condition and these a result of castration-resistant disease. fndings have identifed several potential targets for Since Huggins and Hodges’ report of the dra- therapeutic intervention. These include drugs that are matic clinical effects of suppressing serum testos- more active or less toxic chemotherapy agents; drugs terone levels in men with advanced prostate cancer that induce androgen deprivation; drugs that target in 1941, hormone therapy (also called androgen the androgen receptor and/or androgen synthesis; deprivation therapy [ADT]) has become widely drugs that target specifc pathways, including ang- accepted as the mainstay of therapy for the treat- genesis and tyrosine kinase inhibitors, endothelin ment of advanced prostate cancer. ADT combined antagonists and matrix metalloproteinase inhibitors; with radiation therapy is a standard of care in the and immunologic approaches. Many of these agents treatment of men with locally advanced prostate seem promising and the rationale and effcacy of cancer on the basis of evidence that shows improved these emerging therapies remain to be validated in survival. The role of ADT in the management of future clinical trials.

More books from Springer New York

Cover of the book Enhancing Cognitive Fitness in Adults by
Cover of the book Computational Biology by
Cover of the book Rigidity and Symmetry by
Cover of the book Springer Handbook of Acoustics by
Cover of the book An Introduction to Kolmogorov Complexity and Its Applications by
Cover of the book Off School, In Court by
Cover of the book Adolescents and Adults with Autism Spectrum Disorders by
Cover of the book National Intellectual Capital and the Financial Crisis in Denmark, Finland, Iceland, Norway, and Sweden by
Cover of the book Edmond Halley’s Reconstruction of the Lost Book of Apollonius’s Conics by
Cover of the book Fast Hopping Frequency Generation in Digital CMOS by
Cover of the book Intervention Research in Learning Disabilities by
Cover of the book Ischemia and Loss of Vascular Autoregulation in Ocular and Cerebral Diseases by
Cover of the book Handbook on Data Centers by
Cover of the book America’s Most Sustainable Cities and Regions by
Cover of the book The Corporeal Identity by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy